( OTC-BB:MCET )

News from multicell technologies, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 10, 2014, 08:40 ET MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application

 MultiCell Technologies, Inc. (OTC: MCET) has filed a U.S. patent application covering the design and therapeutic use of novel, next-generation...


Aug 25, 2014, 08:51 ET MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer

 MultiCell Technologies, Inc. (OTC: MCET) has been issued U.S. patent 8,809,290 covering novel drug compositions and platform technologies...


Mar 20, 2014, 08:39 ET MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has filed additional U.S. and international patent applications covering MCT-485 and its...


Jan 15, 2014, 08:39 ET MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a U.S. provisional patent application concerning composition of matter,...


Nov 13, 2013, 08:13 ET MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a second U.S. patent application concerning methods and formulations to...


Oct 02, 2013, 08:00 ET MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the signing of a new sponsored research agreement with Anand...


Aug 06, 2013, 08:00 ET MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and Genisphere LLC will collaborate on the development of targeted MCT-485...


May 16, 2013, 08:00 ET MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the filing of a U.S. patent application concerning methods and...


Dec 26, 2012, 08:00 ET MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) presented at the 2012 American Society for Cell Biology® (ASCB®) Annual...


Oct 22, 2012, 17:30 ET Grant G. Miller Joins Board of MultiCell Technologies

MultiCell Technologies, Inc. (MCET.OB), a clinical-stage biopharmaceutical company, has added Grant G. Miller to its board of directors. Mr. Miller...


Sep 27, 2012, 08:00 ET MultiCell Technologies To Announce Positive Preclinical Results at 2012 ASCB Meeting

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the acceptance by the American Society for Cell...


Sep 06, 2012, 13:49 ET Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies

 MultiCell Technologies, Inc. (MCET.OB), a clinical-stage biopharmaceutical company, has added Scott Lukeman, Ph.D., to its board of...


Aug 14, 2012, 12:35 ET MultiCell Announces Results of Shareholders' Meeting

 MultiCell Technologies, Inc. (OTCBB: MCET.OB), a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools...


Aug 10, 2012, 08:00 ET MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the updated preclinical research results for MCT-465 and...


May 16, 2012, 08:00 ET MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce representatives from the Company will present preclinical...


Feb 16, 2012, 08:30 ET Xenogenics Received Rights to Polyanhydride Compounds Drug Delivery Patent

 Xenogenics Corporation, a subsidiary of MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has exclusive license rights to a...


Jan 03, 2012, 08:30 ET MultiCell Technologies Receives Final Payment Under QTDP Program

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has received the final cash grant award payment of $303,102 under the U.S....


Jul 11, 2011, 08:30 ET MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) ("MultiCell") today announced that it entered into a sponsored research agreement with...


May 31, 2011, 08:30 ET MultiCell Technologies is Granted Stem Cell Patent

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent...


Nov 02, 2010, 08:00 ET MultiCell Technologies Receives $733,437 Cash Grant Award Under U.S. Government's Qualifying Therapeutic Discovery Project Program

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) announces it has received cash grant awards under the U.S. government's Qualifying...


Oct 19, 2010, 08:00 ET MultiCell's Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the...


Aug 02, 2010, 08:00 ET MultiCell Technologies Applies for Qualifying Therapeutic Discovery Project Grants

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announces it has submitted four separate grant applications under the U.S. government's...


Jul 30, 2010, 08:00 ET MultiCell Technologies Launches New Web Site

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has launched a new website with a fresh new look and updated information about discovery...


Jun 14, 2010, 08:00 ET MultiCell Hires Clinical Research Organization to Manage MCT-125 Phase IIb Clinical Trial

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has retained Clinical Development & Support Services, Ltd. (CDSS) of Cheshire, England...


Apr 26, 2010, 08:00 ET MultiCell Technologies Is Granted European Patent for the Treatment of Cancer

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today that it has been granted a European patent (EP 1539819B1) covering certain...